Executive Director of Business Development, Ology Bioservices, Inc., and Nanotherapeutics, Inc.
Leslie Molony, Ph.D. is the former Senior Director, Business Development at Sanford Burnham Prebys Medical Discovery Institute (SBP). In this role, Dr. Molony led the Institute’s activities to develop and implement strategies for establishing new collaborations, licensing technology, and spinning off companies based on research coming out of the Institute with an emphasis on activity at the Lake Nona site in Orlando, Florida.
Dr. Molony began her career as a drug discovery researcher in the pharmaceutical industry then gained business and financial experience as a business development practitioner. She has worked for global consulting firms to commercialize life sciences assets :EBD Group, Recombinant Capital and ProPharma Partners. She has also served as a senior business development executive for Sunesis Pharmaceuticals and Nanotherapeutics. Dr. Molony has successfully developed and negotiated alliances, licenses and partnerships for both public and private companies. She has deep experience identifying, valuing and analyzing commercial potential of early stage technologies. Since 2005, Dr. Molony has managed private, early stage, biopharma companies, beginning as Interim Chief Executive of St. Charles Pharmaceuticals, and most recently, co-founder, President & CEO of Transgeneron Therapeutics.
Dr. Molony joined SBP in August of 2010. As Senior Director of Business Development, she has successfully negotiated license agreements and strategic alliances, and represented the Institute on the BioFlorida Board of Directors, bioOrlando, and the Florida Research Consortium. Dr. Molony is also actively engaged in entrepreneurial development, assisting several faculty members with their life sciences start up activities.
Leslie obtained her B.S. in Physics and a Ph.D. in Cell Biology (biophysics), both from Duke University, and completed postdoctoral studies at the University of North Carolina in Chapel Hill. She studied Financial Management at the University of California at San Diego.